Department of General Internal Medicine, Kobe City Medical Centre General Hospital, Kobe City, Hyogo, Japan
Volume 35, Issue 1, March 2024
Sign in to download the Issue in PDF format.
1878971162
Mediterr J Rheumatol 2024;35(1):195-6
Article Links
Transient Aortitis after COVID-19 mRNA Vaccination
References
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.
- Tang X, Liu F, Li Q, Fu H, Wang J, Mao J. De Novo Vasculitis after COVID-19 Vaccination. Curr Rheumatol Rev 2023;19:151–8.
- Gilio M, De Stefano G. Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine. Intern Emerg Med 2022;17:1239–41.
- Katsouli OK, Lainis VG, Kapellos GG, Vlachoyiannopoulos PG. Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine. Mediterr J Rheumatol 2023;34(1):97–100.
- Aoki K, Yamamoto S, Tochitani K. Transient Large-vessel Vasculitis after COVID-19 mRNA Vaccination. Intern Med 2022;61:2083–4.
- Noda S, Hanai S, Ito R, Kobayashi Y, Nakagomi D. Isolated thoracic aortitis following mRNA vaccination against SARS-CoV-2. QJM 2023:hcad126. doi: 10.1093/qjmed/hcad126. Online ahead of print.
- Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–4.
- Costello F, Dalakas MC. Cranial neuropathies and COVID-19: neurotropism and autoimmunity. Neurology 2020;95:195–6.
- Abu Hassan F, Abu Alhalawa M, Majdoubehv Y, Nepal A, Sufan SS. COVID-19 Aortitis: A Review of Published Cases. Cureus 2022;14:e22226.
- Zhang C, Maruggi G, Shan H, Li J. Advances in mRNA Vaccines for Infectious Diseases. Front Immunol 2019;10:594.
- Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel) 2021;9:435.